Edition:
United States

Neptune Technologies & Bioressources Inc (NEPT.TO)

NEPT.TO on Toronto Stock Exchange

3.67CAD
20 Apr 2018
Change (% chg)

$-0.06 (-1.61%)
Prev Close
$3.73
Open
$3.68
Day's High
$3.78
Day's Low
$3.63
Volume
68,451
Avg. Vol
237,797
52-wk High
$4.41
52-wk Low
$0.86

Chart for

About

Neptune Technologies & Bioressources Inc. is a solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. The Company's products... (more)

Overall

Beta: 0.54
Market Cap(Mil.): $289.13
Shares Outstanding(Mil.): 78.78
Dividend: --
Yield (%): --

Financials

  NEPT.TO Industry Sector
P/E (TTM): 13.28 31.01 33.60
EPS (TTM): 0.28 -- --
ROI: 13.52 13.60 13.19
ROE: 28.41 15.26 15.00

BRIEF-Neptune Technologies & Bioressources Q3 ‍Net Income $1.3 Mln Vs $9.4 Mln

Feb 14 Neptune Technologies & Bioressources Inc :

Feb 14 2018

BRIEF-Neptune, Tetra Bio-Pharma Enter Co-Development Agreement For Purified Cannabinoid Oil-Based Products Targeting Pain, Inflammation

* NEPTUNE AND TETRA BIO-PHARMA ENTER CO-DEVELOPMENT AGREEMENT FOR PURIFIED CANNABINOID OIL-BASED PRODUCTS TARGETING PAIN AND INFLAMMATION Source text for Eikon: Further company coverage:

Feb 12 2018

BRIEF-Neptune And Tetra Bio-Pharma Sign Co-Development Agreement

* NEPTUNE AND TETRA BIO-PHARMA ENTER CO-DEVELOPMENT AGREEMENT FOR PURIFIED CANNABINOID OIL-BASED PRODUCTS TARGETING PAIN AND INFLAMMATION

Feb 12 2018

BRIEF-Neptune Technologies Extends Global Maxsimil Licence To Cannabis-Derived Products​

Nov 27 Neptune Technologies & Bioressources Inc :

Nov 27 2017

BRIEF-Neptune Q2 revenue C$6.8 million versus C$11.6 million

* Neptune Technologies & Bioressources Inc - ‍gain of $23.9 million realized from sale of Krill Oil business​

Nov 14 2017

Earnings vs. Estimates